| |
Journal articles |
|
2011 |
|
|
|
2010 |
|
|
|
2009 |
|
|
2008 |
R Coccurello, A Caprioli, R Conti, O Ghirardi, F Borsini, P Carminati, A Moles (2008) Olanzapine (LY170053,
2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine), but
not the novel atypical antipsychotic ST2472
(9-piperazin-1-ylpyrrolo[2,1-b][1,3]benzothiazepine), chronic administration
induces weight gain, hyperphagia, and metabolic dysregulation in mice J Pharmacol Exp Ther 326: 3. 905-11 sep Abstract: Notes:
|
2006 |
A Bartolomucci, G La Corte, R Possenti, V Locatelli, A E Rigamonti, Torsello
A, E Bresciani, I Bulgarelli, R Rizzi, F Pavone, F R D'Amato, C Severini, Mignogna
G, A Giorgi, M E Schininà, G Elia, C Brancia, G L Ferri, R Conti, B Ciani, Pascucci
T, G Dell'Omo, E E Muller, A Levi, A Moles (2006) TLQP-21, a VGF-derived peptide,
increases energy expenditure and prevents the early phase of diet-induced
obesity. Proc Natl Acad Sci 103: 39. 14584-9 sep Abstract: Notes:
|
|
|
2003 |
F Giannessi, P Pessotto, E Tassoni, P Chiodi, R Conti, F De Angelis, N Dell'Uomo, R Catini, R Deias, M O Tinti, P Carminati, Arduini A J Med Chem (2003) Discovery of a
long-chain carbamoyl aminocarnitine derivative, a reversible carnitine
palmitoyltransferase inhibitor with antiketotic and antidiabetic activity J Med Chem 46: 2. 303-9 jan Abstract: Notes:
|
|
|
2001 |
F Giannessi, P Chiodi, M Marzi, P Minetti, P Pessotto, F De Angelis, E Tassoni, R Conti, F Giorgi, M Mabilia, N Dell'Uomo, S Muck, M O Tinti, P Carminati, A Arduini (2001) Reversible carnitine palmitoyltransferase inhibitors with broad
chemical diversity as potential antidiabetic agents. J Med Chem 44: 15. 2383-6 jul Abstract: Notes:
|
1991 |
|
